Linhao Mm Cong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Linhao Mm Cong has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Guicheng Mm Kuang
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication - Hailan Mm Yang
Department of Neurosurgery, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China
1 shared publication Haitao Mm Liu
Department of Neurosurgery, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China
1 shared publication- Hang Ji
Department of Neurosurgery, West China Hospital, Sichuan University
1 shared publication - Haogeng Sun
West China Hospital of Sichuan University
1 shared publication - Yi Liu
Department of Neurosurgery, West China Hospital, Sichuan University, China
1 shared publication
Latest Publications
- Open Access
- 5 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (23) , e49108
Causal effects of mental disorders on stroke subtypes: A proteome-wide Mendelian randomization and mediation analysis
Observational studies have demonstrated associations between mental disorders and stroke, yet causal relationships and potential molecular mechanisms remain elusive. To clarify this, we performed a bidirectional 2-sample Mendelian randomization (MR) analysis using genome-wide association studies summary statistics to assess the causal effects of 7 major mental disorders (schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, attention-deficit/hyperactivity disorder [ADHD], Alzheimer disease, and Parkinson disease) on stroke subtypes. Analyses were divided into discovery and validation cohorts of European ancestry, followed by MRlap and meta-analysis to obtain pooled estimates. To explore potential circulating protein mediators, 4907 plasma cis-protein quantitative trait loci (cis-pQTLs) from deCODE Genetics were screened, followed by Bayesian co-localization and 2-step MR mediation analyses. Our findings revealed that ADHD was consistently associated with an increased risk of any stroke (AS), any ischemic stroke (AIS), and particularly large-artery atherosclerotic stroke (LAS; odds ratio = 1.455; 95% confidence interval: 1.077–1.967). Mediators screening showed genetic liability to ADHD was linked to elevated circulating matrix metallopeptidase-12 (MMP12; β = 0.141, P = .005), which conferred protection against AIS and LAS, potentially lowering LAS risk by 7.5%. In conclusion, this MR study suggests ADHD is a causal risk factor for ischemic stroke, especially LAS. Paradoxically, circulating MMP12 acts as a protective mediator, modestly reducing this risk by 7.5%. These findings require validation in future experimental and cohort studies.
- 5 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (23) , e49108
Open AccessCausal effects of mental disorders on stroke subtypes: A proteome-wide Mendelian randomization and mediation analysis
Observational studies have demonstrated associations between mental disorders and stroke, yet causal relationships and potential molecular mechanisms remain elusive. To clarify this, we performed a bidirectional 2-sample Mendelian randomization (MR) analysis using genome-wide association studies summary statistics to assess the causal effects of 7 major mental disorders (schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, attention-deficit/hyperactivity disorder [ADHD], Alzheimer disease, and Parkinson disease) on stroke subtypes. Analyses were divided into discovery and validation cohorts of European ancestry, followed by MRlap and meta-analysis to obtain pooled estimates. To explore potential circulating protein mediators, 4907 plasma cis-protein quantitative trait loci (cis-pQTLs) from deCODE Genetics were screened, followed by Bayesian co-localization and 2-step MR mediation analyses. Our findings revealed that ADHD was consistently associated with an increased risk of any stroke (AS), any ischemic stroke (AIS), and particularly large-artery atherosclerotic stroke (LAS; odds ratio = 1.455; 95% confidence interval: 1.077–1.967). Mediators screening showed genetic liability to ADHD was linked to elevated circulating matrix metallopeptidase-12 (MMP12; β = 0.141, P = .005), which conferred protection against AIS and LAS, potentially lowering LAS risk by 7.5%. In conclusion, this MR study suggests ADHD is a causal risk factor for ischemic stroke, especially LAS. Paradoxically, circulating MMP12 acts as a protective mediator, modestly reducing this risk by 7.5%. These findings require validation in future experimental and cohort studies.